Abstract
The ability to generate in vitro cultures of neuronal cells has been instrumental in advancing our understanding of the nervous system. Rodent models have been the principal source of brain cells used in primary cultures for over a century, providing insights that are widely applicable to human diseases. However, therapeutic agents that showed benefit in rodent models, particularly those pertaining to aging and age-associated dementias, have frequently failed in clinical trials. This discrepancy established a potential “translational gap” between human and rodent studies that may at least partially be explained by the phylogenetic distance between rodent and primate species. Several non-human primate (NHP) species, including the common marmoset (Callithrix jacchus), have been used extensively in neuroscience research, but in contrast to rodent models, practical approaches to the generation of primary cell culture systems amenable to molecular studies that can inform in vivo studies are lacking. Marmosets are a powerful model in biomedical research and particularly in studies of aging and age-associated diseases because they exhibit an aging phenotype similar to humans. Here, we report a practical method to culture primary marmoset neurons and astrocytes from brains of medically euthanized postnatal day 0 (P0) marmoset newborns that yield highly pure primary neuron and astrocyte cultures. Primary marmoset neuron and astrocyte cultures can be generated reliably to provide a powerful NHP in vitro model in neuroscience research that may enable mechanistic studies of nervous system aging and of age-related neurodegenerative disorders. Because neuron and astrocyte cultures can be used in combination with in vivo approaches in marmosets, primary marmoset neuron and astrocyte cultures may help bridge the current translational gap between basic and clinical studies in nervous system aging and age-associated neurological diseases.
Similar content being viewed by others
Change history
02 February 2022
A Correction to this paper has been published: https://doi.org/10.1007/s11357-022-00524-4
References
Bracken MB. Why animal studies are often poor predictors of human reactions to exposure. J R Soc Med. 2009;102(3):120–2.
Zeiss CJ, Allore HG, Beck AP. Established patterns of animal study design undermine translation of disease-modifying therapies for Parkinson’s disease. PLoS One. 2017;12(2):e0171790.
Abbott DH, Barnett DK, Colman RJ, Yamamoto ME, Schultz-Darken NJ. Aspects of common marmoset basic biology and life history important for biomedical research. Comp Med. 2003;53(4):339–50.
Kishi N, Sato K, Sasaki E, Okano H. Common marmoset as a new model animal for neuroscience research and genome editing technology. Develop Growth Differ. 2014;56(1):53–62.
Ross C, Salmon AB. Aging research using the common marmoset: focus on aging interventions. J Nutr Health Aging. 2019;5(2):97–109.
Munger EL, Takemoto A, Raghanti MA, Nakamura K. Visual discrimination and reversal learning in aged common marmosets (Callithrix jacchus). Neurosci Res. 2017;124:57–62.
Phillips KA, Watson CM, Bearman A, Knippenberg AR, Adams J, Ross C, et al. Age-related changes in myelin of axons of the corpus callosum and cognitive decline in common marmosets. Am J Primatol. 2019;81(2):e22949.
Ross CN, Adams J, Gonzalez O, Dick E, Giavedoni L, Hodara VL, et al. Cross-sectional comparison of health-span phenotypes in young versus geriatric marmosets. Am J Primatol. 2019;81(2):e22952.
Sadoun A, Rosito M, Fonta C, Girard P. Key periods of cognitive decline in a nonhuman primate model of cognitive aging, the common marmoset (Callithrix jacchus). Neurobiol Aging. 2019;74:1–14.
Tardif SD, Mansfield KG, Ratnam R, Ross CN, Ziegler TE. The marmoset as a model of aging and age-related diseases. ILAR J. 2011;52(1):54–65.
Miller CT, Freiwald WA, Leopold DA, Mitchell JF, Silva AC, Wang X. Marmosets: a neuroscientific model of human social behavior. Neuron. 2016;90(2):219–33.
Mashiko H, Yoshida AC, Kikuchi SS, Niimi K, Takahashi E, Aruga J, et al. Comparative anatomy of marmoset and mouse cortex from genomic expression. J Neurosci. 2012;32(15):5039–53.
Tardif SD. Marmosets as a translational aging model-introduction. Am J Primatol. 2019;81(2):e22912.
Finch CE, Austad SN. Primate aging in the mammalian scheme: the puzzle of extreme variation in brain aging. Age (Dordr). 2012;34(5):1075–91.
Choudhury GR, Daadi MM. Charting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson’s disease. PLoS One. 2018;13(8):e0202770.
Van Skike CE, et al. Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer’s disease and vascular cognitive impairment. Am J Physiol Heart Circ Physiol. 2018;314(4):H693–703.
Pomilio C, Gorojod RM, Riudavets M, Vinuesa A, Presa J, Gregosa A, et al. Microglial autophagy is impaired by prolonged exposure to beta-amyloid peptides: evidence from experimental models and Alzheimer’s disease patients. Geroscience. 2020;42(2):613–32.
Schafer MJ, LeBrasseur NK. The influence of GDF11 on brain fate and function. Geroscience. 2019;41(1):1–11.
Qiu G, Wan R, Hu J, Mattson MP, Spangler E, Liu S, et al. Adiponectin protects rat hippocampal neurons against excitotoxicity. Age (Dordr). 2011;33(2):155–65.
Tokuno H, Moriya-Ito K, Tanaka I. Experimental techniques for neuroscience research using common marmosets. Exp Anim. 2012;61(4):389–97.
Hashikawa T, Nakatomi R, Iriki A. Current models of the marmoset brain. Neurosci Res. 2015;93:116–27.
Mertens J, Reid D, Lau S, Kim Y, Gage FH. Aging in a dish: iPSC-derived and directly induced neurons for studying brain aging and age-related neurodegenerative diseases. Annu Rev Genet. 2018;52:271–93.
Chang CY, Ting HC, Liu CA, Su HL, Chiou TW, Harn HJ, Lin SZ. Induced Pluripotent Stem Cells: A Powerful Neurodegenerative Disease Modeling Tool for Mechanism Study and Drug Discovery. Cell Transplant. 2018;27(11):1588–602.
Kim K, Doi A, Wen B, Ng K, Zhao R, Cahan P, et al. Epigenetic memory in induced pluripotent stem cells. Nature. 2010;467(7313):285–90.
Kim K, Zhao R, Doi A, Ng K, Unternaehrer J, Cahan P, et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells. Nat Biotechnol. 2011;29(12):1117–9.
Polo JM, Liu S, Figueroa ME, Kulalert W, Eminli S, Tan KY, et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol. 2010;28(8):848–55.
Bar-Nur O, Russ HA, Efrat S, Benvenisty N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell. 2011;9(1):17–23.
Ghosh Z, Wilson KD, Wu Y, Hu S, Quertermous T, Wu JC. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One. 2010;5(2):e8975.
Doss MX, Sachinidis A. Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications. Cells. 2019;8(5):403.
Penney J, Ralvenius WT, Tsai LH. Modeling Alzheimer’s disease with iPSC-derived brain cells. Mol Psychiatry. 2020;25(1):148–67.
Wang W, Jin K, Mao XO, Close N, Greenberg DA, Xiong ZG. Electrophysiological properties of mouse cortical neuron progenitors differentiated in vitro and in vivo. Int J Clin Exp Med. 2008;1(2):145–53.
Evans MS, Collings MA, Brewer GJ. Electrophysiology of embryonic, adult and aged rat hippocampal neurons in serum-free culture. J Neurosci Methods. 1998;79(1):37–46.
Harris RA, Tardif SD, Vinar T, Wildman DE, Rutherford JN, Rogers J, et al. Evolutionary genetics and implications of small size and twinning in callitrichine primates. Proc Natl Acad Sci U S A. 2014;111(4):1467–72.
Chen Y, Holstein DM, Aime S, Bollo M, Lechleiter JD. Calcineurin beta protects brain after injury by activating the unfolded protein response. Neurobiol Dis. 2016;94:139–56.
Lin DT, Wu J, Holstein D, Upadhyay G, Rourk W, Muller E, et al. Ca2+ signaling, mitochondria and sensitivity to oxidative stress in aging astrocytes. Neurobiol Aging. 2007;28(1):99–111.
Nelson GM, Guynn JM, Chorley BN. Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method. J Vis Exp. 2017;127:55911. https://doi.org/10.3791/55911.
Harris VM. Protein detection by simple Western analysis. Methods Mol Biol. 2015;1312:465–8.
LeBlanc A. Increased production of 4 kDa amyloid beta peptide in serum deprived human primary neuron cultures: possible involvement of apoptosis. J Neurosci. 1995;15(12):7837–46.
Schildge S, Bohrer C, Beck K, Schachtrup C. Isolation and culture of mouse cortical astrocytes. J Vis Exp. 2013;71:50079.
Sun X, Hu X, Wang D, Yuan Y, Qin S, Tan Z, et al. Establishment and characterization of primary astrocyte culture from adult mouse brain. Brain Res Bull. 2017;132:10–9.
Gradisnik L, Maver U, Bosnjak R, Velnar T. Optimised isolation and characterisation of adult human astrocytes from neurotrauma patients. J Neurosci Methods. 2020;341:108796.
Homman-Ludiye J, Merson TD, Bourne JA. The early postnatal nonhuman primate neocortex contains self-renewing multipotent neural progenitor cells. PLoS One. 2012;7(3):e34383.
Mor E, Cabilly Y, Goldshmit Y, Zalts H, Modai S, Edry L, et al. Species-specific microRNA roles elucidated following astrocyte activation. Nucleic Acids Res. 2011;39(9):3710–23.
Hui CW, Zhang Y, Herrup K. Non-neuronal cells are required to mediate the effects of neuroinflammation: results from a neuron-enriched culture system. PLoS One. 2016;11(1):e0147134.
Ferrer I, García MA, González IL, Lucena DD, Villalonga AR, Tech MC, et al. Aging-related tau astrogliopathy (ARTAG): not only tau phosphorylation in astrocytes. Brain Pathol. 2018;28(6):965–85.
Correale J, Farez MF. The role of astrocytes in multiple sclerosis progression. Front Neurol. 2015;6:180.
Nagele RG, D’Andrea MR, Lee H, Venkataraman V, Wang HY. Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains. Brain Res. 2003;971(2):197–209.
Spanic E, et al. Role of microglial cells in Alzheimer’s disease tau propagation. Front Aging Neurosci. 2019;11:271.
Oberheim NA, Takano T, Han X, He W, Lin JHC, Wang F, et al. Uniquely hominid features of adult human astrocytes. J Neurosci. 2009;29(10):3276–87.
Boghdadi AG, Teo L, Bourne JA. The neuroprotective role of reactive astrocytes after central nervous system injury. J Neurotrauma. 2020;37(5):681–91.
Fernandez E, Ross C, Liang H, Javors M, Tardif S, Salmon AB. Evaluation of the pharmacokinetics of metformin and acarbose in the common marmoset. Pathobiol Aging Age Relat Dis. 2019;9(1):1657756.
Lee HJ, Gonzalez O, Dick EJ Jr, Donati A, Feliers D, Choudhury GG, et al. Marmoset as a model to study kidney changes associated with aging. J Gerontol A Biol Sci Med Sci. 2019;74(3):315–24.
Reveles KR, Patel S, Forney L, Ross CN. Age-related changes in the marmoset gut microbiome. Am J Primatol. 2019;81(2):e22960.
Yun JW, Ahn JB, Kang BC. Modeling Parkinson’s disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal care. Lab Anim Res. 2015;31(4):155–65.
Sharma G, Huo A, Kimura T, Shiozawa S, Kobayashi R, Sahara N, et al. Tau isoform expression and phosphorylation in marmoset brains. J Biol Chem. 2019;294(30):11433–44.
Philippens IH, Ormel PR, Baarends G, Johansson M, Remarque EJ, Doverskog M. Acceleration of amyloidosis by inflammation in the amyloid-beta marmoset monkey model of Alzheimer’s disease. J Alzheimers Dis. 2017;55(1):101–13.
Rodriguez-Callejas JD, Fuchs E, Perez-Cruz C. Evidence of tau hyperphosphorylation and dystrophic microglia in the common marmoset. Front Aging Neurosci. 2016;8:315.
Funding
These studies were supported by Merit Review Award 2I0 1BX002211-05A1 from the US Department of Veterans Affairs Biomedical Laboratory Research and Development Service, NIH/NIA R01AG057964-01, the Robert L. Bailey and daughter Lisa K. Bailey Alzheimer’s Fund in memory of Jo Nell Bailey to VG, a William & Ella Owens Medical Research Foundation Grant, the San Antonio Medical Foundation, and the JMR Barker Foundation to VG. These studies were also supported by an award to VG through the NCATS/NIH Clinical and Translational Science Award grant UL1TR002645. SAH was supported by a Career Development (1 IK2 BX003798-01A1) award from the US Department of Veterans Affairs Biomedical Laboratory Research and Development Service. AOD was supported by NIA Training Grant T32AG021890. ABS was supported by NIH/NIA AG050797, the San Antonio Claude D. Pepper Older Americans Independence Center award (NIH/NIA P30 AG044271), and the San Antonio Nathan Shock Center of Excellence in the Biology of Aging (NIH/NIA P30 AG013319).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The UTHSCSA Institutional Animal Care and Use Committee (IACUC) regularly monitored marmoset housing and animal conditions to ensure all guidelines for the health and safety of the animals were met. This research was reviewed and approved by the UTHSCSA IACUC and experiments were conducted in compliance with the US Public Health Service’s Policy on Humane Care and Use of Laboratory Animals and the Guide for the Care and Use of Laboratory Animals and adhered to the American Society of Primatologists (ASP) principles for the ethical treatment of non-human primates.
Disclaimer
The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PNG 211 kb).
About this article
Cite this article
Dorigatti, A.O., Hussong, S.A., Hernandez, S.F. et al. Primary neuron and astrocyte cultures from postnatal Callithrix jacchus: a non-human primate in vitro model for research in neuroscience, nervous system aging, and neurological diseases of aging. GeroScience 43, 115–124 (2021). https://doi.org/10.1007/s11357-020-00284-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-020-00284-z